DNA repair signature is associated with anthracycline response in triple negative breast cancer patients
β Scribed by A. A. Rodriguez; A. Makris; M. F. Wu; M. Rimawi; A. Froehlich; B. Dave; S. G. Hilsenbeck; G. C. Chamness; M. T. Lewis; L. E. Dobrolecki; D. Jain; S. Sahoo; C. K. Osborne; J. C. Chang
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 326 KB
- Volume
- 123
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Changing the major histocompatibility complex (MHC) class I phenotype is a pivotal strategy of tumor cells to circumvent an effective immune response and is associated with tumor progression in cancer patients. Epithelial cells in bone marrow have been detected in various tumor types, but the clinic
## Abstract 90K (Macβ2 BP) expression was evaluated by immunohistochemistry in paraffinβembedded tissue from a consecutive series of lymphβnode negative breast cancer patients who did not receive adjuvant systemic treatment. An independent series of patients served as validation set. The associatio
S-phase fraction (SPF) is a reference for cell-kinetic analysis. In this study, the links between SPF and the essential enzymes participating in the pyrimidine synthesis were investigated in breast cancer and their relationships with the natural history of the disease were compared. We measured thym